News tagged with tb
Management of TB cases falls short of international standards
The management of tuberculosis cases in the European Union (EU) is not meeting international standards, according to new research.
Feb 09, 2012 |
not rated yet |
0
Treatment for tuberculosis can be guided by patients' genetics
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
Feb 07, 2012 |
not rated yet |
0
The link between TB and a gene mutation that causes lung cancer
Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease ...
Jan 18, 2012 |
not rated yet |
0
Indian experts probing 'untreatable' TB cases
The Indian government on Tuesday dispatched a team of medical experts to the financial capital, Mumbai, to assess reports of a handful of cases of apparently untreatable tuberculosis.
Jan 17, 2012 |
not rated yet |
0
India reports new TB strain resistant to all drugs
Indian doctors have reported the country's first cases of "totally drug-resistant tuberculosis," a long-feared and virtually untreatable form of the killer lung disease.
Jan 16, 2012 |
5 / 5 (3) |
1
Discordance among commercially-available diagnostics for latent TB infection
In populations with a low prevalence of tuberculosis (TB), the majority of positives with the three tests commercially available in the U.S for the diagnosis of TB are false positives, according to a new study.
Dec 09, 2011 |
not rated yet |
0
US urges shorter treatment for TB
US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.
Dec 08, 2011 |
not rated yet |
0
Vaccine targeting latent TB enters clinical testing
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The ...
Medicine & Health / Medications
Dec 01, 2011 |
not rated yet |
0
New tuberculosis research movement needed
In this week's PLoS Medicine, Christian Lienhardt from the WHO in Geneva, Switzerland and colleagues announce that the Stop TB Partnership and the WHO Stop TB Department have launched the TB Research Movement.
Nov 30, 2011 |
2 / 5 (1) |
0
Researchers validate preclinical effectiveness of TB drug target
In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten ...
Nov 29, 2011 |
not rated yet |
0
Decrease in observed rate of TB at a time of economic recession
The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause ...
Nov 07, 2011 |
not rated yet |
0
Latest discovery in the fight against tuberculosis announced
New research from the Trudeau Institute may help in the ongoing fight against tuberculosis. Dr. Andrea Cooper's lab has discovered a connection between the development of new lymphoid tissue within the lung and protection ...
Oct 18, 2011 |
not rated yet |
0
Tuberculosis cases decline worldwide: WHO
For the first time on record, fewer people worldwide are getting sick from tuberculosis, but cash is short in the fight against drug-resistant forms of the disease, the World Health Organization said Tuesday.
Oct 11, 2011 |
not rated yet |
0
Smoking could lead to 40 million excess tuberculosis deaths by 2050
Between 2010 and 2050, smoking could be responsible for 40 million excess deaths from tuberculosis (TB), according to research published in the British Medical Journal today.
Oct 05, 2011 |
1 / 5 (1) |
1
Tuberculosis bacterium's outer cell wall disarms the body's defense to remain infectious
The bacterium that causes tuberculosis has a unique molecule on its outer cell surface that blocks a key part of the body's defense. New research suggests this represents a novel mechanism in the microbe's evolving efforts ...
Oct 03, 2011 |
5 / 5 (3) |
0
|
